Details

Autor(en) / Beteiligte

• Bureau, Christophe
• Péron, JM
• Bouisson, Michèle
• Danjoux, Marie
• Selves, Janick
• Bioulac-Sage, Paulette
• Balabaud, Charles
• Torrisani, Jérome
• Cordelier, Pierre
• Buscail, Louis
• Vinel, Jean Pierre

Titel

Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma

Ist Teil von

• Journal of gastroenterology and hepatology, 2008-01, Vol.23 (1), p.78-86

Ort / Verlag

Melbourne, Australia: Blackwell Publishing Asia

Erscheinungsjahr

2008

Quelle

MEDLINE

Beschreibungen/Notizen

• Background and Aims:  Macronodules (MN) occurring in cirrhosis are considered to be precursor lesions for hepatocellular carcinoma (HCC). However, early molecular events in hepatocellular carcinogenesis are poorly understood. The aim of this study was to compare gene expression profiling between cirrhotic tissues, MN, and HCC, to identify genes early involved in liver carcinogenesis. Methods:  Tissues were obtained from explanted livers: nine cirrhosis, 10 MN, and seven HCC. Total RNAs were extracted by RNeasy and reverse transcribed with labelled [33P]‐αATP. Hybridations were performed on Atlas Human Cancer 1.2 membranes (1176 genes). Results:  A two‐way hierarchical clustering algorithm successfully isolated specific gene expression profiles when comparing MN, cirrhosis, and HCC. A total of 16 and 14 genes were up‐ and down‐expressed, respectively, in HCC as compared to cirrhotic tissues. The molecular signature of MN was characterized by the down‐expression of 23 and 42 genes as compared to cirrhosis and HCC, respectively. Among them, Klf6 was down‐expressed in all MN samples whereas it was over‐expressed in cirrhosis and HCC. This result was confirmed at RNA level by quantitative real time–polymerase chain reaction and at protein level by Western blotting. However, no mutation in the exon 2 of Klf6 was detected. Conclusion:  We identified a molecular signature of MN characterized by a down‐expression of several genes. One of them, Klf6 was found to be down‐expressed in all MN without evidence of somatic mutations in the exon 2. This gene could be involved at an early stage of hepatocarcinogenesis.